Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator

被引:5
作者
Bakker, AHF [1 ]
Nieuwenbroek, NME [1 ]
Verheijen, JH [1 ]
机构
[1] TNO,PG,GAUBIUS LAB,2301 CE LEIDEN,NETHERLANDS
来源
PROTEIN ENGINEERING | 1995年 / 8卷 / 12期
关键词
domain-domain interaction; hybrid proteins; tissue-type plasminogen activator; urokinase;
D O I
10.1093/protein/8.12.1295
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibrin-dependent plasminogen activation by tissue-type plasminogen activator (t-PA) is in part associated with the presence of the kringle 2 domain in t-PA, Within this kringle 2 domain a lysyl-binding site has been described, The plasminogen to plasmin conversion by urokinase-type plasminogen activator (u-PA), in contrast to that of t-PA, is not enhanced in the presence of fibrin, Within the u-PA kringle domain no lysyl-binding site is found, To study whether introduction of a lysyl-binding site in the u-PA kringle domain will make u-PA a fibrin-dependent plasminogen activator, three stretches of amino acid residues of the u-PA kringle domain (A(28)-Q(33), D-55-N-57 and G(67)-V-72) were substituted by three stretches of amino acids from the corresponding positions of the kringle 2 domain of t-PA (M(28)-K-33, D-55-D-57 and N-67-W-72). These changes resulted in the creation of the lysyl-binding site consensus of the kringle 2 domain (K-33, D-55, D-57, W-62 and W-72) in the u-PA kringle, However, the resulting u-PA mutant did not interact with lysyl-Sepharose, nor did it display fibrin-enhanced plasminogen activation in the presence of soluble fibrin mimic, When the kringle domain of u-PA was replaced by the kringle 2 domain of t-PA, similar results were obtained, The hybrid protein hardly interacted with lysyl-Sepharose and the plasminogen activation was not enhanced in the presence of fibrin mimic, However, the N-terminal fragment isolated from this hybrid molecule (consisting of growth factor domain and kringle 2 domain) did interact with lysyl-Sepharose, suggesting that in the hybrid molecule a functional lysyl-binding site is present but not operational, Indeed, lysine analogue (E-aminocaproic acid) sensitive binding of isolated t-PA kringle 2 domain to u-PA could be observed, The modified u-PA kringle, the wild type u-PA kringle and the kringle 2 of the u-PA hybrid were also placed N-terminal of the protease domain of t-PA, As expected, the t-PA mutant consisting of the kringle 2 domain and the protease domain bound to lysyl-Sepharose and showed fibrin-dependent plasminogen activation, Further, the hybrid molecule consisting of the u-PA kringle placed N-terminal of the t-PA protease domain did not display these features, Introduction of the modified u-PA kringle N-terminal of the t-PA protease domain resulted in a very weak interaction with lysyl-Sepharose, Despite the high overall similarity in primary structure of the modified u-PA kringle and t-PA kringle 2 (68%), no fibrin-dependent plasminogen activation of this hybrid molecule was observed, The above-mentioned results question the concept that the structural auto-nomous domains within hybrid plasminogen activators t-PA and u-PA function as autonomous domains and suggest that interactions between the kringle and the protease domain in hybrid molecules strongly influences their functional features.
引用
收藏
页码:1295 / 1302
页数:8
相关论文
共 44 条
[1]  
ASSELBERGS FAM, 1993, THROMB HAEMOSTASIS, V69, P50
[2]  
BAKKER AHF, 1993, J BIOL CHEM, V268, P18496
[3]   ON THE CONVERSION OF HIGH MOLECULAR-WEIGHT UROKINASE TO THE LOW-MOLECULAR WEIGHT FORM BY PLASMIN [J].
BARLOW, GH ;
FRANCIS, CW ;
MARDER, VJ .
THROMBOSIS RESEARCH, 1981, 23 (06) :541-547
[4]   QUANTITATION OF UROKINASE ANTIGEN IN PLASMA AND CULTURE MEDIA BY USE OF AN ELISA [J].
BINNEMA, DJ ;
VANIERSEL, JJL ;
DOOIJEWAARD, G .
THROMBOSIS RESEARCH, 1986, 43 (05) :569-577
[5]   THE CONSTRUCTION AND EXPRESSION OF CHIMERIC UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENES CONTAINING KRINGLE DOMAINS OF HUMAN PLASMINOGEN [J].
BOUTAUD, A ;
CASTELLINO, FJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 303 (02) :222-230
[6]   SOLUTION STRUCTURE OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR KRINGLE-2 DOMAIN COMPLEXED TO 6-AMINOHEXANOIC ACID AN ANTIFIBRINOLYTIC DRUG [J].
BYEON, IJL ;
LLINAS, M .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 222 (04) :1035-1051
[7]  
COLUCCI M, 1993, THROMB HAEMOSTASIS, V69, P446
[8]   BINDING OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR TO LYSINE, LYSINE ANALOGS, AND FIBRIN FRAGMENTS [J].
DEMUNK, GAW ;
CASPERS, MPM ;
CHANG, GTG ;
POUWELS, PH ;
ENGERVALK, BE ;
VERHEIJEN, JH .
BIOCHEMISTRY, 1989, 28 (18) :7318-7325
[9]   SPECIFIC ANIONIC RESIDUES OF THE RECOMBINANT KRINGLE-2 DOMAIN OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR THAT ARE RESPONSIBLE FOR STABILIZATION OF ITS INTERACTION WITH OMEGA-AMINO ACID LIGANDS [J].
DESERRANO, VS ;
CASTELLINO, FJ .
BIOCHEMISTRY, 1993, 32 (14) :3540-3548
[10]   NOVEL EXPRESSION OF CHIMERIC PLASMINOGEN ACTIVATORS IN INSECT CELLS [J].
DEVLIN, JJ ;
DEVLIN, PE ;
CLARK, R ;
OROURKE, EC ;
LEVENSON, C ;
MARK, DF .
BIO-TECHNOLOGY, 1989, 7 (03) :286-292